VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents
VEGF Gene Polymorphism and Response to Intravitreal Anti-VEGF Agents in Neovascular Age-related Macular Degeneration
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
MG
-
Belo Horizonte, MG, Brazil, 30150270
- Recruiting
- Institute of Vision
-
Contact:
- Andre B Ferreira
- Phone Number: 55 31 32743355
- Email: andre@ivisao.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of neovascular age-related macular degeneration
- Visual acuity better than 20/400
- Loading dose with three intravitreal injections of anti-VEGF agents, administred one per month over three months
- Follow-up period of at least six months
Exclusion Criteria:
- Choroidal neovascularization secondary to any other cause than age-related macular degeneration
- Eyes with polypoidal choroidal vasculopathy
- Eyes previously submitted to posterior vitrectomy
- Other diseases that could affect visual acuity
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IV-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.